2025.03.04
来源:WeChat Official Account of Agri-Inputs and Market
作者:Wang Zhenguo
The first reason for the continuous price increase of avermectin and emamectin benzoate is the strong demand in domestic and international markets, with increased export volumes.
On February 5, 2025, the first working day after the Spring Festival, Taiyixin issued a major price increase notice. The notice stated that due to the company's unremitting pursuit of product quality and continuous R&D investments, its Danjian avermectin and Gujian emamectin benzoate technical grade have demonstrated excellent stability, and this non-degradable property is also maintained in formulated products, effectively solving the industry problem of easy degradation of avermectin and emamectin benzoate. However, Taiyixin's unique 3K technology and production process have significantly increased production costs. Considering changes in market supply-demand relationships and rising costs, after in-depth internal research and decision-making, Taiyixin decided to raise prices for all Danjian avermectin and Gujian emamectin benzoate series products, with prices expected to continue rising.
AgroPages Chinese website reported: In January 2025, the Department of Agriculture and Rural Affairs of Heilongjiang Province approved the applications for expanding pesticide production licenses of Heilongjiang Lianshun Biotechnology Co., Ltd. and Heilongjiang Xintai Biotechnology Co., Ltd. Both companies, along with the industry-renowned Ningxia Taiyixin, are subordinate to Duowei Pharmaceutical Group.
In the first quarter of 2025, amid the violent fluctuations in the veterinary drug raw material market, the price curve of tylosin tartrate showed a steep upward trend. As of March 21, the quotation of tylosin tartrate from Ningxia Taiyixin Biotechnology has reached 290 yuan per kilogram (with an actual market transaction price of 280 yuan per kilogram), a cumulative increase of 23.5% from the benchmark price at the beginning of the year, hitting a price peak for this product category in nearly two years. This market aberration seemingly triggered by production capacity contraction actually reflects the deep-seated transformation of China's veterinary drug industry from extensive expansion to a model driven by high-end brands and technology.
In the pharmaceutical and veterinary drug raw material markets, the price trend of lincomycin hydrochloride has always attracted significant attention. As a broad-spectrum antibiotic, lincomycin hydrochloride holds a crucial position in both clinical treatment and livestock and poultry farming. In recent years, its price has shown a remarkable upward trend, and various signs indicate that this trend will continue in the future, with the potential to even break through historical high prices.
在银川举行的第十二届农药行业经济运行分析会上,一则喜讯振奋人心—— 宁夏泰益欣生物科技股份有限公司荣膺 2024 农药行业年度排名第 19 位,销售额高达 37.58 亿元。这一傲人成绩,无疑是泰益欣在农药领域深耕细作、持续创新的有力见证,也为整个行业发展注入了一剂 “强心针” 。